Skip to main content
Cannabis RadioCannabis Radio
ShowsDigital Marketing
Sign in

Loading...

Platform

  • All Shows
  • Search

Company

  • About
  • Contact

Legal

  • Privacy
  • Terms
  • Acceptable Use
  • DMCA Policy

© 2026 Cannabis Radio. All rights reserved.

Blunt Business

Biotechnology And Cannabis

March 11, 202032 min

Biotechnology And Cannabis

Blunt Business

0:00--:--
Biotechnology And Cannabis with Avicanna CEO Aras Azadian. Our next guest is an executive with experience in a range of industries but specializing in Biotechnology and has been involved in several successful startups over the past few years and has been involved in several other projects as a management consultant. Avicanna Inc is a multinational, innovation-focused cannabis company based out of Toronto. Our team met them at the 2020 Benzinga Cannabis Capital Conference and they spoke to the conference about the lack of separation between the medical and adult-use industries. Health Canada granted Avicanna a research license that will allow you to perform research and intellectual property development on cannabinoids at your facility in Toronto. It also allows Avicanna to import active pharmaceutical ingredients into Canada from the company’s own subsidiaries’ facilities in Colombia. Avicanna has been ranked Highest Amongst Global Cannabis Companies in the SAM Corporate Sustainability Assessment. This sustainability index family is among the most prestigious benchmarks for investors who recognize sustainability as the key engine of business models to generate long-term shareholder value and have a positive impact on their investments.

Sponsored by The Buzz CRM

Brought to you by The Buzz CRM

The Buzz CRM proudly sponsors this show.

Enjoy this episode?

Subscribe to Blunt Business for new episodes.

More from Blunt Business

A Psychedelic and Cannabis Research Revolution On the Horizon?

A Psychedelic and Cannabis Research Revolution On the Horizon?

Blunt Business

This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental health disorders.

Apr 22, 202629 min
4/20 Fortune: Critics Say High-Stakes Holiday Losing Its Edge?

4/20 Fortune: Critics Say High-Stakes Holiday Losing Its Edge?

Blunt Business

As the legal landscape evolves, the traditional 4/20 retail boom is showing signs of cooling, with some markets seeing higher sales during the surrounding week than on the holiday itself due to aggressive discounting and operational…

Apr 15, 202624 min
Massachusetts Cannabis Market Overhaul and a Major MSO Files Bankruptcy

Massachusetts Cannabis Market Overhaul and a Major MSO Files Bankruptcy

Blunt Business

The cannabis landscape in Massachusetts and the broader U.S. market is undergoing a significant correction as regulators and major corporations grapple with the industry's economic realities.

Apr 8, 202625 min
Inside New York’s Five-Year Cannabis Chronicle

Inside New York’s Five-Year Cannabis Chronicle

Blunt Business

In this episode of The Blunt Business , the discussion dives deep into the complex landscape of the New York cannabis market as it hits its five-year legalization anniversary . While Governor Kathy Hochul lauds the state’s achievement of…

Apr 1, 202629 min
Loading comments...